(BUSINESS WIRE)--Camargo Pharmaceutical Services, a full-service clinical research organization (CRO) specializing in end-to-end drug development through the 505(b)(2) process, is pleased to announce the Company’s appointment of Ray Dawkins, M.D., as chief medical officer.
